Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma. Reply
- Hungria, V.
- Mateos, M.-V.
ISSN: 1533-4406
Year of publication: 2024
Volume: 391
Issue: 14
Pages: 1364-1365
Type: Letter
Journal:
The New England journal of medicine